Brazilian health biotech—fostering crosstalk between public and private sectors

  title={Brazilian health biotech—fostering crosstalk between public and private sectors},
  author={Rahim Rezaie and Sarah E Frew and Stephen M. Sammut and Maya R Maliakkal and Abdallah S. Daar and Peter A. Singer},
  journal={Nature Biotechnology},
The Brazilian health biotech sector has made considerable progress in recent years toward becoming truly innovative. This sector comprises private enterprises as well as government-controlled institutes and is involved in the development and/or provision of health products for human consumption. To address the sizeable demand for health products for Brazil’s 190 million people, many of whom live in poverty1, the country has taken several concrete steps, legislative and otherwise, to build upon… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
15 Citations
17 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 15 extracted citations


Publications referenced by this paper.
Showing 1-10 of 17 references

Patients over patents, says Brazil health ministry (April

  • M. Peer
  • < markets/2008/04/10…
  • 2008

into Business; Ten Years Promoting Technological Innovation

  • FAPESP. Translating Researc
  • (The State of São Paulo Research Foundation, São…
  • 2008

In Brazil, a conviction on biopiracy charges angers scientists

  • L. Rohter
  • International Herald Tribune (August
  • 2007

Status and Potential of Commercial Bioprospecting Activities in Latin America and the Caribbean

  • F. Quezada
  • (United Nations Publications,
  • 2007

The Brazilian system of innovation in biotechnology: a preliminary study

  • R. Marques
  • J. Technol. Manag. Innov
  • 2007

Intervention of health authorities in patent examination: the Brazilian practice of the prior consent

  • M. Basso
  • Int. J. Intellectual Property Management
  • 2006

Similar Papers

Loading similar papers…